» Articles » PMID: 10342312

Increased Fracture Rate in Diabetes Mellitus and Females After Renal Transplantation

Overview
Journal Transplantation
Specialty General Surgery
Date 1999 May 26
PMID 10342312
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bone disease and fractures after organ transplantation pose severe clinical problems. About 20% of renal transplant patients have type 1 diabetes (IDDM). However, data are scarce in the literature about the occurrence of spontaneous fractures in IDDM patients posttransplantation.

Methods: In this cross-sectional study using a questionnaire and hospital records the prevalence of symptomatic bone disease was investigated in 193 renal transplanted patients with functioning renal grafts 6 months to 23 years after the transplantation.

Results: The frequency of IDDM was 18%. In the total group the rate of osteoporotic fractures posttransplantation was 17%, and the majority of fractures occurred within the first 3 years after the transplantation. A high rate of fractures, 40%, was noted in the diabetes group (P<0.001), compared with 11% in the nondiabetes group. Fractures seen in IDDM were often multiple and located mostly in the appendicular skeleton, i.e., in ankles and feet. Female gender was also associated with an elevated fracture rate, 23% (P<0.05).

Conclusion: An increased incidence of osteoporotic fractures after renal transplantation was found in diabetic and female patients. The mechanism behind bone fragility in IDDM is multifactorial and despite a restored renal function bone disease may progress, and is probably enhanced by the immunosuppressive treatment.

Citing Articles

Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications.

Kuppachi S, Cheungpasitporn W, Li R, Caliskan Y, Schnitzler M, McAdams-DeMarco M Kidney Med. 2022; 4(6):100474.

PMID: 35669410 PMC: 9166366. DOI: 10.1016/j.xkme.2022.100474.


Clinical predictors of incipient vertebral fractures and bone mineral density in kidney transplant patients.

Yavuz D, Aydin K, Apaydin T, Velioglu A, Mert M, Pekkolay Z Eur Spine J. 2022; 31(9):2423-2430.

PMID: 35376984 DOI: 10.1007/s00586-022-07162-6.


Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial.

Jorgensen H, Eide I, Jenssen T, Asberg A, Bollerslev J, Godang K Nutrients. 2021; 13(7).

PMID: 34371870 PMC: 8308635. DOI: 10.3390/nu13072361.


Interventions for preventing bone disease in kidney transplant recipients.

Palmer S, Chung E, McGregor D, Bachmann F, Strippoli G Cochrane Database Syst Rev. 2019; 10:CD005015.

PMID: 31637698 PMC: 6803293. DOI: 10.1002/14651858.CD005015.pub4.


Fracture Risk in Dialysis and Kidney Transplanted Patients: A Systematic Review.

Sidibe A, Auguste D, Desbiens L, Fortier C, Wang Y, Jean S JBMR Plus. 2019; 3(1):45-55.

PMID: 30680363 PMC: 6339558. DOI: 10.1002/jbm4.10067.